scholarly journals Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer

2014 ◽  
Vol 12 (1) ◽  
pp. 378 ◽  
Author(s):  
Jie Zhou ◽  
Shikun Qian ◽  
Weixing He ◽  
Guodong Han ◽  
Hongsheng Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Internal Jugular Vein ◽  
Jugular Vein ◽  
Venous Access ◽  
Access Port ◽  
Venous Access Port

Late complications associated with totally implantable venous access port implantation via the internal jugular vein

2019 ◽  
Vol 28 (6) ◽  
pp. 2761-2768 ◽  
Author(s):  
Shigeaki Tsuruta ◽  
Yasutomo Goto ◽  
Hideo Miyake ◽  
Hidemasa Nagai ◽  
Yuichiro Yoshioka ◽  
...  
Keyword(s):  
Internal Jugular Vein ◽  
Jugular Vein ◽  
Venous Access ◽  
Late Complications ◽  
Access Port ◽  
Port Implantation ◽  
Venous Access Port

scholarly journals Totally implantable venous access port insertion via open Seldinger approach of the internal jugular vein—a retrospective risk stratification of 500 consecutive patients

2021 ◽  
Author(s):  
Felix Becker ◽  
Lennart A. Wurche ◽  
Martina Darscht ◽  
Andreas Pascher ◽  
Benjamin Struecker
Keyword(s):  
Risk Factors ◽  
Internal Jugular Vein ◽  
Jugular Vein ◽  
Intraoperative Complications ◽  
Venous Access ◽  
Access Port ◽  
Oncological Treatment ◽  
Number Of Patients ◽  
Venous Access Port

Abstract Purpose Modern oncological treatment algorithms require a central venous device in form of a totally implantable venous access port (TIVAP). While most commonly used techniques are surgical cutdown of the cephalic vein or percutaneous puncture of the subclavian vein, there are a relevant number of patients in which an additional strategy is needed. The aim of the current study is to present a surgical technique for TIVAP implantation via an open Seldinger approach of the internal jugular vein and to characterize risk factors, associated with primary failure as well as short- (< 30 days) and long-term (> 30 days) complications. Methods A total of 500 patients were included and followed up for 12 months. Demographic and intraoperative data and short- as well as long-term complications were extracted. Primary endpoint was TIVAP removal due to complication. Logistic regression analysis was used to analyze associated risk factors. Results Surgery was primarily successful in all cases, while success was defined as functional (positive aspiration and infusion test) TIVAP which was implanted via open Seldinger approach of the jugular vein at the intended site. TIVAP removal due to complications during the 1st year occurred in 28 cases (5.6%) while a total of 4 (0.8%) intraoperative complications were noted. Rates for short- and long-term complications were 0.8% and 6.6%, respectively. Conclusion While the presented technique requires relatively long procedure times, it is a safe and reliable method for TIVAP implantation. Our results might help to further introduce the presented technique as a secondary approach in modern TIVAP surgery.

scholarly journals Analysis of risk factors for implantable venous access port catheter fracture with internal jugular vein

2020 ◽  
Vol 9 (1) ◽  
pp. 30-36 ◽  
Author(s):  
Ning Ai ◽  
Li Li ◽  
Fenghua Yin ◽  
Zhigang Li ◽  
Cuizhi Geng ◽  
...  
Keyword(s):  
Risk Factors ◽  
Internal Jugular Vein ◽  
Jugular Vein ◽  
Venous Access ◽  
Port Catheter ◽  
Access Port ◽  
Venous Access Port ◽  
Catheter Fracture

Totally Implantable Venous Access Port Systems: Implant Depth-based Complications in Breast Cancer Therapy - A Comparative Study

2021 ◽  
Vol 27 ◽  
Author(s):  
Kuo Chen ◽  
Narasimha M. Beeraka ◽  
Yuanting Gu ◽  
Jingruo Li ◽  
Mikhail Sinelnikov ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Venous Access ◽  
Breast Cancer Patients ◽  
Breast Cancer Therapy ◽  
Access Port ◽  
Group A ◽  
Venous Access Port ◽  
Group B ◽  
Group D

Background: Totally implantable venous access port system (TIVAPS) is widely used in breast cancer therapy; TIVAPS has several associated complications depending on the depth of implantation in breast cancer (BC) patients during continuous infusional chemotherapy regimens. The purpose of this study is to find out the optimal depth of TIVAPS implantation to reduce the incidence of complications during infusional chemotherapy. Methods: This study reviewed the depth TIVAPS implantation in the internal jugular vein in 1282 breast cancer patients over a ten-year period (2009-2019), and associated complications. We segregated the patients as 5 groups: ‘Group A (depth < 4 mm), Group B (depth of 4-8 mm), Group C (depth of 8-12 mm), and Group D (depth of 12-16 mm), and Group E (depth of > 16 mm)’. Consequently, the ‘internal complications’ such as infection, venous thrombotic syndrome, catheter folding & migration, extravasation, whereas the ‘external complications’ viz., inflammation, local hematoma, local cutaneous reactions, and port exteriorization were significantly analyzed during TIVAPS implantation at different depths in BC patients. Results: Overall incidence of ‘internal complications’ such as infections, venous thrombotic syndrome, catheter folding & migration, and extravasation was comparatively lesser in Group C (8-12 mm) than Group A, Group B, Group D, and Group E, respectively. Mainly, the external complications such as inflammation Group C (8-12 mm) (p<0.01) were lesser (6.8%, 3/44 cases) than Group A, Group B, Group D, Group E. On a similar note, the local hematoma, and local cutaneous reaction, and port exteriorization were observed as ‘5% (1/20 cases), 4.2% (2/47 cases), and (3.2%, 1/31 cases)’ in Group C patients (p<0.01), which were comparatively lesser than the other groups. Conclusion: Subcutaneous implantation of TIVAPS at a depth of 8-12 mm could be preferred due to the lowest incidence of internal and external complications compared to the incidence of these complications in other groups; this depth could be referred to as the safe and convenient implantation depth for the effective delivery of chemotherapy regimen in BC patients without difficulty in transcutaneous access to the port.

scholarly journals Clinical application of totally implantable venous access ports in patients with breast cancer

2020 ◽  
Author(s):  
Peng Zhang ◽  
Xueli Mo ◽  
Jun Du ◽  
Changsheng Fan ◽  
Jie Dong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Treatment ◽  
Clinical Application ◽  
Venous Access ◽  
Chemotherapeutic Drugs ◽  
Access Port ◽  
Male Patients ◽  
Venous Access Port

Abstract Background Totally implantable venous access port (TIVAP) has become an effective approach for venous access chemotherapy in cancer treatment. We aimed to show the important procedures of clinical application of TIVAP and complications management in breast cancer.Patients and Methods From January 2013 to December 2017, patients with breast cancer who took TIVAP operation were investigated. The key procedures of TIVAP conduct and its complications were evaluated in this study.Results One hundred and ten ports were applied to 110 patients with breast cancer. All ports were successfully implanted in all patients including 108 male and 2 male patients. Patients were followed for an average of 275 days. Conclusion It is safe and effective of TIVAP implantation by blind puncture applied in patients with breast cancer. Chemotherapeutic drugs delivery on the placement day seems safe and showed no more complications.

Sign in / Sign up

Export Citation Format

Share Document